Cadrenal Therapeutics, Inc. CVKD
Set alert
1.07 USD +0.03 +2.88%
As of Nov 3, 11:07 AM ET
1.05 Day range 1.10
0.816 52-week range 13.37
- YTD
- -84.22%
- 1 year
- -92.07%
- Open
- 1.05
- Prev close
- 1.04
- Mkt cap
- 3.82M
- Vol
- 6.04K
- Avg vol
- 473.07K
- EPS
- -4.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.05
- High
- 1.10
- Forward P/E
- -3.02
- Beta
- 0.00
- Short ratio
- 1.17
- Inst. own
- 4.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 14.77
- 200-d avg
- 9.61
- 1y target
- 35.67
5D chart
Signals (62)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:30 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 12:25 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 12:10 PM | 22 hours ago |
| RSI: Overbought | Nov 2, 10:40 AM | 1 day ago |
| SMA: Bullish | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bullish | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:25 PM | 3 days ago |
Newest 20 of 62.
Analyst view
Consensus: none
Price target (mean) 35.67 +3233.3% upside
Now 1.07
- Target (low)
- 30.00
- Target (mean)
- 35.67
- Target (high)
- 45.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.87 | -2.03 – -1.70 | -1.88 | +0.5% | 0 | 0.0% | 2 |
| Next quarter | -2.15 | -2.15 – -2.15 | -1.50 | -43.3% | 0 | 0.0% | 1 |
| Current year | -7.80 | -8.02 – -7.57 | -8.23 | +5.3% | 0 | 0.0% | 2 |
| Next year | -4.27 | -5.76 – -2.78 | -7.80 | +45.2% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 18, 2023 | Noble Capital Markets | Initiated | — | Outperform |
| Nov 20, 2023 | HC Wainwright & Co. | Initiated | — | Buy |